The MOH approved " The Hospital care development policy" in Feb 2014. Development of the strategic plan of implementation of the policy is ongoing.
6 technical working groups have established on 15 Sep 2011. 60% of working group members are female. Hospital policy and strategy development WG was established by Health Minister's order #212/2011.
Current system of hospital facility and equipment auditing and capital planning at MOH has been reviewed. Capital planning system assessment was completed. Recommendations on establishment of the capital planning system is provided
Local NGO which was recruited in Oct 2013 for advocacy has carried out a patient satisfaction survey in the first quarter 2014 under supervision of the national consultant on gender, and social poverty.
Additional funding of $25 mln in loans for establishing demonstration hospital was approved on 7 February 2013. Te consultant firm to plan the hospital was recruited in Jan 2014.
Ongoing. Concept design and functional planning of new hospital is developed based on identifyed gender specific needs
Ongoing. Hospital licensing system was reviewed. The report prepared by GVG consulting firm under THSDP is available. Licensing regulation was reviewed by ministerial order in 2012. New revision was discussed by PSC in March 2013.
Revision of four specialist curricula has been started.
Ongoing. An inter-sectoral working group on postgraduate medical specialist training chaired by Vice Minister of Health was established in Sep 2013. Two reports including (i) a situation analysis of the current residency programs, and (ii) recommendations on how to reform the residency programs were presented in September 2013 to the multi-sectorial working group chaired by the Vice-minister of Health. The working group has reached a consensus on key reform issues on postgraduate specialist training system in Mongolia proposed by the consultants and finalized the proposed revisions of the law and other relevant government documents in December 2013. Recommendations to reform a system of postgraduate medical specialist training were developed and approved by PSC in June 2013 and discussed in the consultative meeting held in Oct, 2013 involving representatives of MOH, MoES, HSUM, HDC and professional boards of MOH. Legal framework for reforming the system is developed and submitted to MOH in Dec 2013 to Jan 2014.
The training of the first batch of 25 managers started in October 2013. MOH will also submit to ADB its proposal on further actions toward the institutionalization of the hospital management training course.
The project objective of establishing a drug regulatory agency (DRA) is reflected in the Government Action Plan for 2012-2016 as the establishment of a Food and Drug Agency (FDA). The National Security Council also issued a resolution in January 2013 to establish an FDA. The project consultants have provided technical input to MOH on drug regulatory functions to be integrated in a future FDA. However, various other options for institutional arrangements for drug regulatory authority, such as DRA and GASI are being considered by the government and a consensus has not been reached yet.
All participant lists show the total number of women and men.
Baseline review of drug regulatory functions was undertaken using WHO methodology in Nov-Dec 2011 and results were discussed at the relevant stakeholders meeting on 24 Jan 2012. The positive score was 46.9%.
Ongoing. The design of a new lab building the building complies with ISO per-qualification criteria, as confirmed by the ISO expert, who visited DCL in Dec 2012. The construction of new Drug Control laboratory (DCL) was completed in Feb 2013. The project supported the laboratory in developing an Action Plan for achieving ISO17025. DCL is continuing to work with OPM toward getting ISO17025, the international accreditation as planned under the project.
SWOT analysis and baseline Good Laboratory Practice assessment of the medicine and bio-preparation laboratory of the Central Lab, GASI was conducted and findings were presented in Jan-March 2013.
The Drug Control Laboratory of the National Reference Laboratory of GASI has passed ISO/IEC 17025 standard accreditation by ANAB (American National Accreditation Board). ANAB- a signatory of the International Accreditation Forum and the International Laboratory Accreditation Cooperation has certified the laboratory against ISO/IEC 17025 standards. Technical assessors of ANAB conducted a thorough evaluation of all factors relevant to a laboratory's function and confirmed the laboratory is capable to produce precise, accurate calibration and test data.
National MNS 5524:2011 on GMP was assessed against WHO GMP Guidelines and International GMP requirements. National GMP standard is being revised.
In 2012, all 33 local manufactories were assessed against national standards. The findings revealed that only 4-5 could comply with. OPM team is continuously providing technical support to potentially capable manufactories in improving their setting. For example, OPM conducted review of conceptual design of new GMP facility of Monos pharma (formal assessment), Astra pharma and Nakhia in June 2012. In 2012 total of 7 manufactories were undergone a gap analysis toward GMP. In 2013 additional 11 manufactories involved in assessment. Based on technical assistance and recommendation provided by OPM some of them are continuously improving their operations (IVCO, Tsombo, Astra pharma. Monos pharma, New Nakhia, Tun pharma, Degd pharma).
Survey started to measure knowledge, attitude and practices of hospital and district pharmacists.
ADB approved to fund the first part of Prevalence of counterfeit and substandard drugs in Selected Regions of Mongolia using a Stratified Random Sample Survey which covers provinces (7 Mar 2012) and the contract was made with the researcher from School of Pharmacy, HSUM (22 Mar 2012). The second part of the project proposal to determine prevalence of counterfeit and substandard drugs in Ulaanbaatar, after several discussions at the WHO Country Representative Office, was agreed to be funded by WHO through CRO. The survey completed in May 2013. The survey report is available.